Frailty in Hematologic Malignancy

od Koll, Thuy, Rosko, Ashley E.
Izdano u Curr Hematol Malig Rep (2018)

The pharmacologic management of multiple myeloma in older adults

od Dempsey, Jessica L., Johns, Andrew, Rosko, Ashley E., Lazarus, Hillard M.
Izdano u Expert Opin Pharmacother (2019)

Approach to the Older Adult With Multiple Myeloma

od Mina, Roberto, Bringhen, Sara, Wildes, Tanya M., Zweegman, Sonja, Rosko, Ashley E.
Izdano u Am Soc Clin Oncol Educ Book (2019)

Advances in Management for Older Adults With Hematologic Malignancies

od Rosko, Ashley E., Cordoba, Raul, Abel, Gregory, Artz, Andrew, Loh, Kah Poh, Klepin, Heidi D.
Izdano u J Clin Oncol (2021)

A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging

od Rosko, Ashley E., Olin, Rebecca L., Artz, Andrew, Wildes, Tanya M., Stauder, Reinhard, Klepin, Heidi D.
Izdano u J Geriatr Oncol (2018)

Bone Health and Survival in Women With Multiple Myeloma

od Rosko, Ashley E., Hade, Erinn M., Li, Wenjun, Ing, Steven, Jackson, Rebecca D., Paskett, Electra D., Naughton, Michelle J.
Izdano u Clin Lymphoma Myeloma Leuk (2018)

Incidence and survival of hematological cancers among adults ages ≥75 years

od Krok‐Schoen, Jessica L., Fisher, James L., Stephens, Julie A., Mims, Alice, Ayyappan, Sabarish, Woyach, Jennifer A., Rosko, Ashley E.
Izdano u Cancer Med (2018)

Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women’s Health Initiative

od Cespedes Feliciano, Elizabeth M., Hohensee, Chancellor, Rosko, Ashley E., Anderson, Garnet L., Paskett, Electra D., Zaslavsky, Oleg, Wallace, Robert B., Caan, Bette J.
Izdano u JAMA Netw Open (2020)

Ninety-Minute Daratumumab Infusion is Safe in Multiple Myeloma

od Barr, Hallie, Dempsey, Jessica, Waller, Allyson, Huang, Ying, Williams, Nita, Sharma, Nidhi, Benson, Don M., Rosko, Ashley E., Efebera, Yvonne A., Hofmeister, Craig C.
Izdano u Leukemia (2018)

Most Multiple Myeloma Patients have Low Testosterone

od John, Sonya, Sharma, Nidhi, Sborov, Douglas, Williams, Nita, Jones, Desirée, Benson, Don M, Efebera, Yvonne A, Rosko, Ashley E, Vincent, Jennifer, Hofmeister, Craig C
Izdano u Leuk Lymphoma (2018)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients

od Cottini, Francesca, Huang, Ying, Williams, Nita, Bumma, Naresh, Khan, Abdullah M., Chaudhry, Maria, Devarakonda, Srinivas, Efebera, Yvonne A., Benson, Don M., Rosko, Ashley E.
Izdano u Front Oncol (2021)

Implementing a multidisciplinary approach for older adults with Cancer: geriatric oncology in practice

od Presley, Carolyn J., Krok-Schoen, Jessica L., Wall, Sarah A., Noonan, Anne M., Jones, Desiree C., Folefac, Edmund, Williams, Nicole, Overcash, Janine, Rosko, Ashley E.
Izdano u BMC Geriatr (2020)

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

od Mian, Hira, Grant, Shakira J., Engelhardt, Monika, Pawlyn, Charlotte, Bringhen, Sara, Zweegman, Sonja, Stege, Claudia A.M., Rosko, Ashley E., von Lilienfeld-Toal, Marie, Wildes, Tanya M.
Izdano u J Geriatr Oncol (2020)

Transplant-ineligible newly diagnosed multiple myeloma: current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper

od Grant, Shakira J., Mian, Hira S., Giri, Smith, Boutin, Melina, Dottorini, Lorenzo, Neuendorff, Nina R., Krok-Schoen, Jessica L., Nikita, Nikita, Rosko, Ashley E., Wildes, Tanya M., Zweegman, Sonja
Izdano u J Geriatr Oncol (2020)

Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment

od Rosko, Ashley E, McColl, Karen S, Zhong, Fei, Ryder, Christopher B, Chang, Ming-Jin, Sattar, Abdus, Caimi, Paolo F, Hill, Brian T, Al-Harbi, Sayer, Almasan, Alexandru, Distelhorst, Clark W
Izdano u J Leuk (Los Angel) (2014)

A Phase 1 Trial of Single Agent Reolysin in Patients with Relapsed Multiple Myeloma

od Sborov, Douglas W, Nuovo, Gerard J, Stiff, Andrew, Mace, Thomas, Lesinski, Gregory B., Benson, Don M., Efebera, Yvonne A, Rosko, Ashley E., Pichiorri, Flavia, Grever, Michael R., Hofmeister, Craig C
Izdano u Clin Cancer Res (2014)

T-cell transcriptional profiling and immunophenotyping uncover LAG3 as a potential significant target of immune modulation in multiple myeloma

od Lucas, Fabienne, Pennell, Michael, Huang, Ying, Benson, Don M., Efebera, Yvonne A., Chaudhry, Maria, Hughes, Tiffany, Woyach, Jennifer A., Byrd, John C., Zhang, Suohui, Jones, Desiree, Guan, Xiangnan, Burd, Christin E., Rosko, Ashley E.
Izdano u Biol Blood Marrow Transplant (2019)

Use of a Comprehensive Frailty Assessment to Predict Morbidity in Patients with Multiple Myeloma undergoing Transplant

od Rosko, Ashley E., Huang, Ying, Benson, Don M., Efebera, Yvonne A., Hofmeister, Craig, Jaglowski, Samantha, Devine, Steven, Bhatt, Geetika, Wildes, Tanya M., Dyko, Alanna, Jones, Desirée, Naughton, Michelle J., Byrd, John C., Burd, Christin E.
Izdano u J Geriatr Oncol (2018)

Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant

od Cho, Yu Kyoung, Irby, Donald J., Li, Junan, Sborov, Douglas W., Mould, Diane R., Badawi, Mohamed, Dauki, Anees, Lamprecht, Misty, Rosko, Ashley E., Fernandez, Soledad, Hade, Erinn M., Hofmeister, Craig C., Poi, Ming, Phelps, Mitch A.
Izdano u CPT Pharmacometrics Syst Pharmacol (2018)

Associations of high-dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial

od Cho, Yu Kyoung, Sborov, Douglas W., Lamprecht, Misty, Li, Junan, Wang, Jiang, Hade, Erinn M., Gao, Yue, Tackett, Karen, Williams, Nita, Benson, Don M., Efebera, Yvonne A., Rosko, Ashley E., Devine, Steven M., Poi, Ming, Hofmeister, Craig C., Phelps, Mitch A.
Izdano u Clin Pharmacol Ther (2017)